Cancer Science & Research

Cancer Science & Research

Open Access
ISSN: 2639-8478

Archive – 2018 | Volume 1 | Issue 3

Research Article DOI: 10.33425/2639-8478.1011
Study on Quality of Life of Breast Cancer Patients Receiving First Line Chemotherapy in a Tertiary Care Hospital Karachi, Pakistan

Authors: Arifa Aziz, Zeenat Shaheen.

Review Article DOI: 10.33425/2639-8478.1012
The Development of LPPC in PAS in Blood Transfusion Centre

Authors: Jongkol Akahat, Thipaporn Jaroonsirimaneekul, Nuanchan Mungkhunkhamchaw, Kutcharin Phunikhom.

Review Article DOI: 10.33425/2639-8478.1013
SCHIZENCEFALIA - A Bibliographic Review of Clinical Aspects

Authors: Carla Chiste T Santos, Chadya Samia Soares Pacondes De Miranda, Kelly De Jesus Menezzes Da Silva, Iel Marciano de Moraes Filho, Fellipe José Gomes Queiroz, Fernando Vianna Cabral Pucci.

Research Article DOI: 10.33425/2639-8478.1014
Results of A Multicentric Study of Patients with Multiple Myeloma Treated with Three Different Triplet Regimens Including Bortezomib

Authors: Alvarado Ibarra Martha, Mujica Martínez Aldo, Pérez Zuñiga Juan Manuel, Hernández Ruiz Eleazar, Paredes Lozano Eugenia Patricia, Trejo Gómora Jorge, Ron Guerrero Carlos, Alvarez Vera José Luis, Ortiz Zepeda Maricela, Mena Zepeda Veronica, De la Peña Celaya Antonio, Espitia Rios Eugenia, Ramí

Research Article DOI: 10.33425/2639-8478.1015
Irreversible Cholecystokinin-1 Receptor Antagonists PNB-028/81: N-isobutyl-5-hydroxy-5-aryl-pyrrol-2-ones as Experimental Therapeutic Agents against Colon and Pancreatic Cancer

Authors: Lattmann E, Russell ST, Balaram PN, Narayanan R, Lattmann P.

Editor-in-Chief
Lee Guek Eng
Lee Guek Eng
Department of Medical Oncology | National University of Singapore

View full editorial board →
Journal Metrics
Impact Factor 2.4*
Acceptance Rate 75%
Time to first decision 6-10 Days
Submission to acceptance 12-15 Days